NCT03451292: A reported trial by Grifols Therapeutics LLC
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03451292 |
|---|---|
| Title | Prevention of Mortality With Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 24, 2018 |
| Completion date | May 21, 2024 |
| Required reporting date | May 21, 2025, midnight |
| Actual reporting date | May 21, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |